ERBB2 and breast carcinoma: Given that Her-2 enriched breast cancer is a well validated, biologically distinct subtype with copy number amplification of the ERBB2 gene, we selected a clustering result which grouped HER2− enriched samples consistently into a single cluster to be used for all subsequent analyses.